Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
07/09/2023 20:36
Sept 7 (Reuters) - Paratek Pharmaceuticals Inc PRTK.O :
* LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS
PARATEK
PHARMACEUTICALS STOCKHOLDERS VOTE FOR THE ACQUISITION BY GURNET
POINT CAPITAL AND NOVO HOLDINGS
Source text for Eikon: ID:nGNX1RZdDJ
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million